HAL Id: inserm-02160928
https://www.hal.inserm.fr/inserm-02160928
Submitted on 20 Jun 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-entific research documents, whether they are pub-lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.
Human autologous tolerogenic dendritic cells impair T-cell proliferation through contact-independent
mechanisms
Eros Marín, Laurence Bouchet-Delbos, Maria-Cristina Cuturi, Aurelie Moreau
To cite this version:
Eros Marín, Laurence Bouchet-Delbos, Maria-Cristina Cuturi, Aurelie Moreau. Human autologous tolerogenic dendritic cells impair T-cell proliferation through contact-independent mechanisms. 22nd NAT congress ”Immunotherapies in transplantation and Cancer”, Jun 2017, Nantes, France. �inserm-02160928�
Treg Thxkx0 KTDC CDE( KllogeneicymDC Solubleyfactors Solubleyfactors TGFv CDE(mDC CDE(mDC CDE(mDC(KTDC CDE(mDC CDE(mDC(KTDC KTDC Monocytey elutriation KIMV GMvCSF RPMI GMvCSF ILvE Hydays DonoryK DonoryB
y
y
y
y
y
y
HumanGautologousGtolerogenicGdendriticGcellsGimpairGT2cellG
proliferationGthroughGcontact2independentGmechanisms
ATDCGimpairGCD4
)GT2cellGproliferationGthroughG
contactGindependentGmechanisms
Background
ATDCGimpairGTh1GandGTh17GproliferationGwhileG
promoteGTreg
ATDCGimpairGCD4)T2cellGproliferationGthroughGG0/G1G
phaseGblockadeGwithoutGinducingGapoptosisGnorGanergyG
ATDCGinduceGtheGgenerationGofG/deGnovo/GTregG
partiallyGthroughGtheGproductionGofGTGF2G
Conclusion
Model
Counts Suppressionyassay Transwellyassayy
yy
yy
Kutologousy tolerogenicy dendriticy cellsy BKTDCpy havey beeny demonstratedy toy bey abley toy increasey heart)yskinyandypancreaticyisletyallograftysurvivalsyinymurineymodelsyandytoybeysafeyinynonvhumany primates,yDueytoytheiryefficacyyandytheirysafety)yKTDCytherapyyhasybeenymovedytoyclinicyinyayfirsty phasey IkIIy clinicaly trialy iny kidneyy transplantationy iny they contexty ofy they ONEy studyy project,y Humany KTDCyareygeneratedyfromyelutriatedymonocytesyculturedyHydaysyinyKIMVymediumysupplementedy withy lowy dosey ofy GMvCSF,y Kftery differentiationy KTDCy displayy ay tolerogenicy dendriticy celly profiley Bi,e,y theyy displayy any immaturey phenotype)y theyy expressy immunomodulatoryy cytokinesy suchy asy ILvx.yandyTGFvyy)ytheyyareyresistantytoymaturationyandytheyyhaveysuppressiveyactivityytowardyTv cellsp,y Thisy projecty aimsy toy determiney they suppressivey mechanismsy ofy humany KTDCy towardy Tv cells,
y
xyCentreydeyRechercheyenyTransplantationyetyImmunologieyUMRx.HE)yINSERM)yUniversitéydeyNantes)yNantes)yFrance
OyInstitutydeyTransplantationyUrologieyNéphrologieyBITUNp)yCHUyNantes)yNantes)yFrance
ErosyMarin
x)O)yLaurenceyBouchetvDelbos
x)O)yMariayCristinayCuturi
x)O)yKurélieyMoreau
x)Oy
FigureG1.GMA.yCDE(yTvcellyproliferationyinysuppressionyassayyandyMB.ytranswellyassay
FigureG3.GBA.GPercentageyofyproliferatingyCDE(tvbet(IFNvyy(yThxycells)y MB.yCDE(ILx0K(yThx0ycells)yandyMC.yCDE(CDOjhiFoxPNhiyTregycellsyy
afterysuppressionyassay
FigureG 4.G MAG andG B.G Suppressiony assayy startingy withy CDE(CDOjvy Tvcellsy
insteady ofy totaly CDE(y Tvcells,G MA.y Percentagey ofy proliferatingy CDE (CDOjhiFoxPNhiyTregycellsyandyMB.yafteryaddingyTGFvyyyblockingyantibody,y
FigureG2.GMA.yCDE(Tvcellycellycycleyandyy MB.G apoptosisy iny suppressiony assay,y G G MC.y Knergyy assay,y First)y CDE(y Tvcellsy
werey culturedy withy allogeneicy KTDCy ory MoDC,y Kftery Hyday)yCDE(yTvcellsywerey recoveredy andy culturedy withy allogeneicy mDC,
Thesey resultsy altogethery showedy thaty lowy dosey GMvCSFvinducedy KTDCy arey ableytoysuppressyCDE(TvcellyproliferationyandytoyinduceyVdeynovoVyTregyinyparty throughytheyexpressionyofyTGFvyy,yMoreoveryweyevincedythatyKTDCyimpairyTv celly proliferationy byy contactvindependenty mechanismsy withouty assotiationy withy apoptosisy nory anergyy buty withy they blockadey ofy celly cycley iny G.kGxy phase,y Inv depthyinvestigationsywillybeyperformedytoydetermineytheymolecularymechanismsy underlyingyKTDC, FigureG1.GBA.ySchematicyrepresentationyofyKTDCyandyMoDCydifferentiation,yInythisy studyyweyusedyMoDCyasycontrolycells,yMB.yModelyofysuppressionyassayyusedyinythisy study,yCDE(TvcellsyareyculturedywithyallogeneicymatureydendriticycellsyBmDCpywithy orywithoutyKTDCyoryMoDCyBautologousytoyCDE(yTvcellsp KTDC Tvcells Or LPS CDE( mDC y MoDC KTDC v v v ( ( v v ( ( v ( ( ( ( v ( j)0O N)H. O)éé U0)0 x.. x.x x.O x.N x.E x.j x.. x.x x.O x.N x.E x.j N)xx O)éU O)é0 éx). x.. x.x x.O x.N x.E x.j x.. x.x x.O x.N x.E x.j Gx_G. 0U)N GO_M é)0E S xx)j . j.K x..K xj.K O..K Oj.K . j.. x).K x)jK O).K Gx_G. éO)x GO_M O)00 S E)0U . j.K x..K xj.K O..K Oj.K . x).K O).K N).K CDE( mDC KTDC v v ( ( v ( ( ( ( mDC CDE(BKTDCp ( v v ( ( CDE(BMoDCp v ( v ( v ( v KnnexinvV DKPI PropidiumyIodide CDE(Tvcellycellycycleyafterysuppressionyassay CDE(Tvcellyapoptosisyafterysuppressionyassay Knergyyassay CDE(mDC CDE(mDC(KTDC CDE(mDC CDE(mDC(KTDC VDeynovoVyTregyinduction VDeynovoVyTregyinductionyiny presenceyofyantivTGFv